Entropy Technologies »

Upstream Bio shares owned by Entropy Technologies

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2026-03-31 $210k 23k 9.00

More positions owned by Entropy Technologies

Cheniere Energy Ord Com New (LNG)
Boston Scientific Corporation (BSX)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Colgate-Palmolive Company (CL)
FedEx Corporation (FDX)
Chevron Corporation (CVX)
Occidental Petroleum Corporation (OXY)
Lockheed Martin Corporation (LMT)
Medtronic Ord SHS (MDT)
PG&E Corporation (PCG)
Palantir Technologies Cl A Ord Cl A (PLTR)
Blackrock (BLK)
Trane Technologies Ord SHS (TT)
Mastercard Cl A Ord Cl A (MA)

View all positions for Entropy Technologies

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
BlackRock
Decheng Capital
Enavate Sciences GP
Vanguard Capital Management
Y-Intercept
Federated Investors
Geode Capital Management
Millennium Management
SEB Asset Management AB
Bain Capital Life Sciences Investors
Woodline Partners
D. E. Shaw & Co
Parkman Healthcare Partners

View all funds holding Upstream Bio